|
|
|
| home > ict > Summer 2018 |
|
|
 PUBLICATIONS |
International Clinical Trials |
|
|
|
|
|
 |
| |
|
|
|
|
|
Regulatory Guidance on Outsourcing
Organising Outsourcing
Martin Robinson at IAOCR delves into the world of outsourcing as a part of clinical trials and provides a detailed account of how to receive advice and guidance through regulatory bodies.
|
|
|
|
Dealing with Data Protection
Protecting Privacy
ICT spoke to Dr Andrew Rut at MyMeds&Me to discuss the all-important topic of patient data safety during clinical trials and the ways in which this sensitive issue should be approached.
|
|
|
|
|
Q&A: Clinical Trial Transparency
Patient Privacy
ICT spoke to Thomas Wicks and Francine Lane at TrialScope about noncompliance, the risks and penalties it can lead to, and how to avoid running afoul of regulators.
|
|
|
|
|
Improving the Clinical Trial Continuum
Perfecting Practices
Investments in new technologies to increase performances, gain greater quality, and encourage optimisation across trials are some of the most pressing topics for companies. Craig Morgan at goBalto provides an insight.
|
|
|
|
|
Event Preview
Let’s Get Clinical
Get a taste of what to expect in this event preview if visiting Partnerships in Clinical Trials Europe this November, including one-to-one meetings, digital partnering, and networking with industry leaders from around the globe.
|
|
|
|
|
|
Using Gamification and Behavioural Economics in Surveys
Gaining from Gamification
Creating a questionnaire for clinical trials can be fraught with difficulties, particularly when attempting to extract as much data as possible from respondents. Dr Keith Meadows at Health Outcome Solutions provides a clearer answer.
|
|
|
|
Translation and Comprehension of Disease Activity
PRO Translation
Language barriers and translation issues when using patient-recorded outcomes over a multinational patient group are an essential consideration. The team at RWS Life Sciences tell us more.
|
|
|
|
Site Engagement Technology
Appreciated and Informed
Using different scenarios to promote the use of site engagement technology, Dani Darasz and Lesley Freese at DrugDev comment on how clean trial data and protocol adherence can be greatly improved.
|
|
|
|
|
|
Q&A: Partnerships in Clinical Trials Europe
Clinical Connections
With the upcoming Partnerships in Clinical Trials Europe event in November quickly approaching, ICT spoke to Louisa Maitland about what visitors can expect from the main streams.
|
|
|
|
|
Robust Insurance Policies
Navigating Global Complexities
Kathryn Moon at Gallagher sheds some light on key insurance considerations, as deciding on a specific insurance policy can be one of the great difficulties a company faces when conducting clinical trials.
|
|
|
|
Clinical Trials Liability Insurance
A Safety Net
Designed to excel if issues arise during any clinical trial, insurance is an essential and continuously evolving entity. Hanna Beaumont at La Playa explains some of the associated complexities in the industry.
|
|
|
|
|
|
Current Trends in Outsourcing
Outsourcing Evolution
Outsourcing has been ongoing in the pharmaceutical industry for many years, but, as the methods develop, which is the right approach? Colin Stanley at ICON Functional Services explains.
|
|
|
|
Functional Outsourcing Versus Full-Service Partnerships
Strategic Selection
Jeff Mayhew and Elizabeth Koury at LabConnect describe the top factors that companies should examine when selecting a strategic partner for assistance in clinical trials.
|
|
|
|
|
End Point
Restricting Remedies
ICT’s Editor Dr Graham Hughes surveys the differing regulations regarding cannabis between the US and UK.
|
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
PCI and CSP Technologies, Inc. Announce Strategic Collaboration for Breakthrough Activ-BlisterTM Solutions
Philadelphia, PA & Auburn, AL – September 17, 2018 PCI Pharma Services (PCI), a full-service provider of specialist outsourced drug manufacturing, clinical trial services, and commercial packaging to the global healthcare industry, is pleased to announce its exclusive collaboration agreement with CSP Technologies, Inc. for U.S. clinical trials and stability testing utilizing Activ-BlisterTM packaging solutions, which help protect and promote speed-to-market for pharmaceutical and medical device products with heightened susceptibility to moisture and gases, especially oxygen.
More info >> |
|
 |
White Papers |
 |
|
Crossing the Blood Brain Barrier (BBB): Which Route to Take?
Aptar Pharma
Aptar Pharma recently hosted an expert panel/roundtable on the various approaches to treating central nervous system (CNS) diseases. This international scientific forum was held in Paris, France on December 5th, 2014. The roundtable was organized to explore and exchange views on the challenges, approaches and opportunities that exist with regard to effectively crossing the blood brain barrier (BBB) and successfully treating a host of CNS diseases.
More info >> |
|
 |
Industry Events |
 |
4th Annual Genome Editing Congress
8-9 November 2018, London, UK
Oxford Global is proud to present its 4thAnnual Genome Editing Congress taking place on 8-9 November 2018 in London. As
part of our Genomics and Synthetic Biology UK series, our congress will
bring together Over 600 delegates representing internationally renowned
research & academic institutions, clinical research institutions and
pharmaceutical companies.
More info >> |
|
|
